Results for psühhoosiga translation from Estonian to English

dementsusega seotud psühhoosiga eakad patsiendid
elderly patients with dementia-related psychosis

eakatel dementsusele kaasneva psühhoosiga patsientidel:
elderly patients with dementia-related psychosis:

aripiprasool ei ole näidustatud dementsusega seotud psühhoosiga patsientide raviks.
aripiprazole is not indicated for the treatment of patients with dementia-related psychosis.

dementsusega seotud psühhoosiga eakatel patsientidel, keda ravitakse antipsühhootikumidega, on suurenenud surmarisk.
elderly patients with dementia-related psychosis treated with antipsychotic substances are at an increased risk of death.

ravimite (dopamiini agonistide) poolt esile kutsutud psühhoosiga parkinsoni tõbe põdevate patsientide
pneumonia, increased body temperature, lethargy, erythema, visual hallucinations and urinary incontinence were observed commonly.

sycresti ei ole heaks kiidetud dementsusega seotud psühhoosiga patsientide raviks ja seda ei soovitata kasutada selles konkreetses patsientide rühmas.
sycrest is not approved for the treatment of patients with dementia-related psychosis and is not recommended for use in this particular group of patients.

56- 99 a) aripiprasooliga eakatel alzheimeri tõvega kaasneva psühhoosiga patsientidel täheldati apipiprasooliga ravitud patsientidel suremuse tõusu võrreldes platseeboga.
56-99 years) of aripiprazole in elderly patients with psychosis associated with alzheimer's disease, patients treated with aripiprazole were at increased risk of death compared to placebo.

ravimite (dopamiini agonistide) poolt esile kutsutud psühhoosiga parkinsoni tõbe põdevate patsientide kliinilises uuringus täheldati väga sageli parkinsoni tõve sümptomaatika süvenemist ja hallutsinatsioone, sagedamini kui platseebo korral.
in clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with parkinson’s disease, worsening of parkinsonian symptomatology and hallucinations were reported very commonly and more frequently than with placebo.

ravim-indutseeritud (dopamiini agonistid) psühhoosiga parkinsoni tõvega patsientide kliinilistes uuringutes teatati väga sageli parkinsoni tõve sümptomaatika süvenemisest ja hallutsinatsioonidest, sagedamini kui platseebo korral.
in clinical trials in patients with drug-induced (dopamine agonist) psychosis associated with parkinson’s disease, worsening of parkinsonian symptomatology and hallucinations were reported very commonly and more frequently than with placebo.

tserebrovaskulaarsed kõrvaltoimed, sealhulgas ajurabandus, eakatel dementsusele kaasneva psühhoosiga patsientidel: kolmes platseebo- kontrollrühmaga uuringus aripiprasooliga eakatel alzheimeri tõvega kaasneva psühhoosiga patsientidel (keskmine vanus 84 a; vahemik 78- 88 a) teatati tserebrovaskulaarsetest kõrvalnähtudest (nt ajurabandus, transitoorne isheemiline atakk), muuhulgas ka surmaga lõppenud juhtudest.
although the causes of deaths were varied, most of the deaths appeared to be either cardiovascular (e. g. heart failure, sudden death) or infectious (e. g. pneumonia) in nature.